This session explores how continuous metabolic monitoring is shaping the future of diabetes and cardiometabolic care. Experts discuss the growing evidence linking CGM-derived metrics to cardiovascular risk and clinical outcomes, review practical recommendations to build CGM expertise across clinical teams, and highlight the expanding role of structured education in improving technology-driven care. The session also looks ahead to continuous ketone monitoring as the next frontier in metabolic management, offering new opportunities for early detection, greater patient safety, and more precise intervention strategies. Together, the session provides a forward-looking overview of how continuous monitoring can transform prevention, clinical decision-making, and outcomes for people with diabetes.